| 1 | [SID17432769] | Active | IC50 | 0.17037 | Luminescence-based biochemical high throughput dose response assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID651971, Type: confirmatory] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Active | | IC50 | 0.17037 [uM] | | BioAssay | Luminescence-based biochemical high throughput dose response assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 651971 | | BioAssay type | confirmatory | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 2 | [SID17432769] | Active | IC50 | 0.22148 | Counterscreen Fluorescent Polarization-based biochemical high throughput orthogonal dose response assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID651989, Type: confirmatory] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Active | | IC50 | 0.22148 [uM] | | BioAssay | Counterscreen Fluorescent Polarization-based biochemical high throughput orthogonal dose response assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 651989 | | BioAssay type | confirmatory | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 3 | [SID17432769] | Active | Potency | 1.2589 | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) [AID1478, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Active | | Potency | 1.2589 [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) | | AID | 1478 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 4 | [SID17432769] | Active | Potency | 1.9953 | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) [AID1476, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) | | AID | 1476 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 5 | [SID17432769] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 6 | [SID17432769] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 7 | [SID17432769] | Active | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID624268, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Active | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 624268 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 8 | [SID17432769] | Active | | | Fluorescent Polarization-based biochemical high throughput orthogonal assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID651607, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Active | | BioAssay | Fluorescent Polarization-based biochemical high throughput orthogonal assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 651607 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 9 | [SID17432769] | Active | | | Luminescence-based biochemical high throughput confirmation assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID624412, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Active | | BioAssay | Luminescence-based biochemical high throughput confirmation assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 624412 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 10 | [SID17432769] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 11 | [SID17432769] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 12 | [SID17432769] | Inactive | Potency | 14.1254 | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase [AID1634, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286418] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase | | AID | 1634 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286418] | | PubMed | | | Data Table |  |
|
| 13 | [SID17432769] | Inactive | Potency | 14.1254 | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase [AID1634, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286418] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase | | AID | 1634 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286418] | | PubMed | | | Data Table |  |
|
| 14 | [SID17432769] | Inactive | Potency | 14.1254 | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase [AID1634, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286418] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase | | AID | 1634 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286418] | | PubMed | | | Data Table |  |
|
| 15 | [SID17432769] | Inactive | Potency | 15.8489 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | Potency | 15.8489 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID17432769] | Inactive | IC50 | 44.359 | Counterscreen for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS): Luminescence-based cell-based high throughput dose response assay to identify compounds that are cytotoxic to Jurkat human T lymphocyte cells [AID651972, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | IC50 | 44.359 [uM] | | BioAssay | Counterscreen for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS): Luminescence-based cell-based high throughput dose response assay to identify compounds that are cytotoxic to Jurkat human T lymphocyte cells | | AID | 651972 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID17432769] | Inactive | EC50 | 260 | Luminescence Cell-Based Dose Retest to Identify Potentiators of Heat Shock Factor 1 (HSF1) [AID435004, Type: confirmatory] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | EC50 | 260 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Identify Potentiators of Heat Shock Factor 1 (HSF1) | | AID | 435004 | | BioAssay type | confirmatory | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 18 | [SID17432769] | Inactive | EC50 | 260 | Luminescence Cell-Based Dose Retest to Identify Potentiators of Heat Shock Factor 1 (HSF1) [AID435004, Type: confirmatory] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | EC50 | 260 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Identify Potentiators of Heat Shock Factor 1 (HSF1) | | AID | 435004 | | BioAssay type | confirmatory | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 19 | [SID17432769] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 20 | [SID17432769] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 21 | [SID17432769] | Inactive | AbsAC40_uM | | Sustained Induction of HSF-1 Measured in Cell-Based System Using Plate Reader - 2038-07_Activator_Dose_CherryPick_Activity [AID602296, Type: confirmatory] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | AbsAC40_uM | [uM] | | BioAssay | Sustained Induction of HSF-1 Measured in Cell-Based System Using Plate Reader - 2038-07_Activator_Dose_CherryPick_Activity | | AID | 602296 | | BioAssay type | confirmatory | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 22 | [SID17432769] | Inactive | AbsAC40_uM | | Sustained Induction of HSF-1 Measured in Cell-Based System Using Plate Reader - 2038-07_Activator_Dose_CherryPick_Activity [AID602296, Type: confirmatory] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | AbsAC40_uM | [uM] | | BioAssay | Sustained Induction of HSF-1 Measured in Cell-Based System Using Plate Reader - 2038-07_Activator_Dose_CherryPick_Activity | | AID | 602296 | | BioAssay type | confirmatory | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 23 | [SID17432769] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 24 | [SID17432769] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 25 | [SID17432769] | Inactive | Potency | | qHTS of IL-2 Activators [AID652025, Type: confirmatory] | Il2 gene product [Mus musculus] [gi:7110653] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of IL-2 Activators | | AID | 652025 | | BioAssay type | confirmatory | | Target | Il2 gene product [Mus musculus] [gi:7110653] | | PubMed | | | Data Table |  |
|
| 26 | [SID17432769] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 27 | [SID17432769] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 28 | [SID17432769] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 29 | [SID17432769] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 [AID1672, Type: screening] | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 | | AID | 1672 | | BioAssay type | screening | | Target | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] | | PubMed | | | Data Table |  |
|
| 30 | [SID17432769] | Inactive | IC50 | | Fluorescence for the identification of compounds that decrease p/CIP protein stability [AID1984, Type: confirmatory] | nuclear receptor coactivator 3 [Mus musculus] [gi:118026946] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Fluorescence for the identification of compounds that decrease p/CIP protein stability | | AID | 1984 | | BioAssay type | confirmatory | | Target | nuclear receptor coactivator 3 [Mus musculus] [gi:118026946] | | PubMed | | | Data Table |  |
|
| 31 | [SID17432769] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex [AID504707, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex | | AID | 504707 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] | | PubMed | | | Data Table |  |
|
| 32 | [SID17432769] | Inactive | Potency | | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 33 | [SID17432769] | Inactive | Potency | | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 34 | [SID17432769] | Inactive | Potency | | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 35 | [SID17432769] | Inactive | Potency | | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID17432769] | Inactive | Potency | | qHTS for Inhibitors of binding or entry into cells for Lassa Virus [AID540256, Type: confirmatory] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of binding or entry into cells for Lassa Virus | | AID | 540256 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID17432769] | Inactive | | | Small Molecules that selectively kill Giardia lamblia: qHTS [AID540267, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Small Molecules that selectively kill Giardia lamblia: qHTS | | AID | 540267 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID17432769] | Inactive | | | A CPE Based HTS Assay for Antiviral Drug Screening Against Dengue Virus [AID540333, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | A CPE Based HTS Assay for Antiviral Drug Screening Against Dengue Virus | | AID | 540333 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID17432769] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID17432769] | Inactive | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity [AID588334, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity | | AID | 588334 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID17432769] | Inactive | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts [AID588335, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts | | AID | 588335 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID17432769] | Inactive | | | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies [AID588358, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies | | AID | 588358 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID17432769] | Inactive | | | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity [AID588436, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity | | AID | 588436 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID17432769] | Inactive | | | uHTS identification of small molecule modulators of myocardial damage [AID588492, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule modulators of myocardial damage | | AID | 588492 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID17432769] | Inactive | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID17432769] | Inactive | IC50 | | A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 [AID588727, Type: confirmatory] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 | | AID | 588727 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID17432769] | Inactive | | | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588692, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588692 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID17432769] | Inactive | | | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors [AID602141, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors | | AID | 602141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID17432769] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID504803, Type: screening] | HTRA1 protein [gi:121945198] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 504803 | | BioAssay type | screening | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|
| 50 | [SID17432769] | Inactive | Potency | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17432769 | | CID | 707837 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|